All CaMKII overexpressing breast cancer cells had increased levels of pERK1/2 and vimentin and decreased levels of E-cadherin (Fig. 8A–E), and MDA-MB-231 cells also possessed elevated levels of pFAK (Fig. 8C,D). This evidence concerns the gene CAMK2G and breast cancer.